These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 19153511

  • 1. Optimizing growth hormone dosing in children with idiopathic short stature.
    Keni J, Cohen P.
    Horm Res; 2009 Jan; 71 Suppl 1():70-4. PubMed ID: 19153511
    [Abstract] [Full Text] [Related]

  • 2. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012 Jan; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG).
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 5. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Sep; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 6. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
    Decker R, Albertsson-Wikland K, Kriström B, Halldin M, Dahlgren J.
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
    [Abstract] [Full Text] [Related]

  • 7. Weight relative to height before and during growth hormone therapy in prepubertal children.
    Kaplowitz PB, Rundle AC, Blethen SL.
    Horm Metab Res; 1998 Sep; 30(9):565-9. PubMed ID: 9808325
    [Abstract] [Full Text] [Related]

  • 8. Comparative proteomic analysis in children with idiopathic short stature (ISS) before and after short-term recombinant human growth hormone (rhGH) therapy.
    Heo SH, Choi JH, Kim YM, Jung CW, Lee J, Jin HY, Kim GH, Lee BH, Shin CH, Yoo HW.
    Proteomics; 2013 Apr; 13(7):1211-9. PubMed ID: 23436750
    [Abstract] [Full Text] [Related]

  • 9. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
    Frindik JP, Kemp SF, Hunold JJ.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():607-12. PubMed ID: 12795361
    [Abstract] [Full Text] [Related]

  • 10. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, Longás AF.
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).
    Park P, Cohen P.
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893
    [Abstract] [Full Text] [Related]

  • 12. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME, Karlsson H.
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [Abstract] [Full Text] [Related]

  • 13. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone treatment for short stature in children born small for gestational age.
    Jung H, Rosilio M, Blum WF, Drop SL.
    Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.
    Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF.
    J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821
    [Abstract] [Full Text] [Related]

  • 16. [The model of height prognosis in children with growth hormone deficiency].
    Kostecka L, Wasikowa R, Noczyńska A, Filipowski H.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jan; 10(2):113-7. PubMed ID: 15504314
    [Abstract] [Full Text] [Related]

  • 17. [Relationship between the polymorphism of growth hormone receptor Ex3 and the efficacy of rhGH treatment in children with idiopathic short stature].
    Lu WL, Wang W, Wang DF, Xiao Y, Huang XP, Dong ZL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Sep; 12(9):730-3. PubMed ID: 20849725
    [Abstract] [Full Text] [Related]

  • 18. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L, Gurrado R, Zecchino C, Manolo F, De Sanctis V, Cisternino M, Caruso-Nicoletti M, Galati M.
    J Pediatr Endocrinol Metab; 1998 Sep; 11 Suppl 3():845-9. PubMed ID: 10091155
    [Abstract] [Full Text] [Related]

  • 19. An auxology-based growth hormone program: update on the Australian experience.
    Werther GA, Wang M, Cowell CT.
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():613-8. PubMed ID: 12795362
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human insulin-like growth factor-I therapy for children with growth disorders.
    Richmond EJ, Rogol AD.
    Adv Ther; 2008 Dec; 25(12):1276-87. PubMed ID: 19066756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.